The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

Apr. 14, 2016
Applicant:

Pathak Holdings, Llc, Phoenix, AZ (US);

Inventor:

Chandrashekhar P. Pathak, Phoenix, AZ (US);

Assignee:

Pathak Holdings, LLC, Phoenix, AZ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 31/155 (2006.01); A61K 9/00 (2006.01); A61K 31/496 (2006.01); A61K 31/7036 (2006.01); A61K 47/34 (2017.01); A61M 37/00 (2006.01); A61K 31/337 (2006.01); A61K 31/727 (2006.01); A61L 27/50 (2006.01); A61L 27/54 (2006.01); A61K 41/00 (2006.01); A61M 5/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/0021 (2013.01); A61K 9/0024 (2013.01); A61K 9/0048 (2013.01); A61K 9/1641 (2013.01); A61K 9/1647 (2013.01); A61K 9/1658 (2013.01); A61K 31/337 (2013.01); A61K 31/496 (2013.01); A61K 31/7036 (2013.01); A61K 31/727 (2013.01); A61K 41/0028 (2013.01); A61K 47/34 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61M 37/0015 (2013.01); A61M 37/0076 (2013.01); A61L 2400/06 (2013.01); A61M 5/3015 (2013.01); A61M 2037/0023 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/3653 (2013.01); C12Y 304/21068 (2013.01); C12Y 304/24069 (2013.01);
Abstract

This invention provide novel compositions, methods and devices for sustained drug delivery. The compositions can include a fluid carrier; a plurality of first polymeric microparticles having a bioactive agent dispersed in the fluid carrier; and a plurality of second polymeric microparticles having a visualization agent dispersed in the fluid carrier with the first microparticles. Alternative compositions can include: a fluid carrier; and a plurality of polymeric microparticles having a bioactive agent encapsulated therein and a visualization agent on a surface of the polymeric microparticles, the plurality of polymeric microparticles being dispersed in the fluid carrier. The microencapsulated sustained drug delivery compositions are deposited using oscillating needle apparatus oscillating at 10-12000 minutes per minutes at an amount of 1.0E-03 mL to 1.0E-16 mL per injection.


Find Patent Forward Citations

Loading…